Encompass Health Corporation $EHC Position Boosted by Signaturefd LLC

Signaturefd LLC raised its holdings in shares of Encompass Health Corporation (NYSE:EHC) by 29.1% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 869 shares of the company’s stock after acquiring an additional 196 shares during the period. Signaturefd LLC’s holdings in Encompass Health were worth $107,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of EHC. Pinnacle Wealth Planning Services Inc. grew its position in Encompass Health by 4.0% in the 1st quarter. Pinnacle Wealth Planning Services Inc. now owns 2,597 shares of the company’s stock valued at $263,000 after buying an additional 99 shares in the last quarter. Caitong International Asset Management Co. Ltd boosted its holdings in shares of Encompass Health by 19.0% in the first quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock valued at $73,000 after acquiring an additional 115 shares in the last quarter. UMB Bank n.a. increased its stake in shares of Encompass Health by 10.9% during the second quarter. UMB Bank n.a. now owns 1,187 shares of the company’s stock valued at $146,000 after acquiring an additional 117 shares during the period. Arlington Trust Co LLC raised its holdings in Encompass Health by 22.9% during the first quarter. Arlington Trust Co LLC now owns 671 shares of the company’s stock worth $68,000 after purchasing an additional 125 shares in the last quarter. Finally, Exchange Traded Concepts LLC lifted its position in Encompass Health by 1.9% in the second quarter. Exchange Traded Concepts LLC now owns 8,095 shares of the company’s stock worth $993,000 after purchasing an additional 152 shares during the period. Institutional investors own 97.25% of the company’s stock.

Wall Street Analyst Weigh In

EHC has been the topic of a number of research reports. Bank of America boosted their price objective on Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a research note on Wednesday, September 10th. Weiss Ratings reiterated a “buy (b+)” rating on shares of Encompass Health in a research report on Saturday, September 27th. KeyCorp upped their price target on shares of Encompass Health from $135.00 to $140.00 and gave the company an “overweight” rating in a report on Tuesday, September 16th. UBS Group boosted their target price on shares of Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Thursday. Finally, Truist Financial raised their target price on shares of Encompass Health from $135.00 to $140.00 and gave the stock a “buy” rating in a report on Thursday, August 14th. One investment analyst has rated the stock with a Strong Buy rating and eight have issued a Buy rating to the company. Based on data from MarketBeat, Encompass Health has an average rating of “Buy” and a consensus target price of $139.86.

Insider Buying and Selling

In related news, EVP Patrick William Tuer sold 1,020 shares of the firm’s stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the transaction, the executive vice president owned 18,846 shares of the company’s stock, valued at approximately $2,329,177.14. This trade represents a 5.13% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 2.00% of the company’s stock.

Encompass Health Stock Performance

Shares of EHC opened at $123.13 on Friday. The company has a market capitalization of $12.40 billion, a PE ratio of 24.10, a PEG ratio of 2.16 and a beta of 0.93. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.06 and a current ratio of 1.06. The company’s 50 day moving average price is $121.25 and its 200 day moving average price is $115.66. Encompass Health Corporation has a 52 week low of $87.85 and a 52 week high of $127.86.

Encompass Health (NYSE:EHC) last issued its earnings results on Monday, August 4th. The company reported $1.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.20 by $0.20. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. The company had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. During the same quarter last year, the business posted $1.11 EPS. The company’s revenue for the quarter was up 12.0% on a year-over-year basis. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. Research analysts expect that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be issued a dividend of $0.19 per share. The ex-dividend date is Wednesday, October 1st. This represents a $0.76 annualized dividend and a dividend yield of 0.6%. This is a positive change from Encompass Health’s previous quarterly dividend of $0.17. Encompass Health’s dividend payout ratio is presently 14.87%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.